Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Recent & Breaking News (OTCQX:MRVFF)

Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets

Canada NewsWire December 31, 2018

Nuvo Pharmaceuticals™ (Ireland) DAC Enters into Resultz® License and Supply Agreement with Heumann Pharma GmbH & Co. Generica KG for Germany

PR Newswire December 21, 2018

Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals

Canada NewsWire November 29, 2018

Nuvo Pharmaceuticals™ Announces 2018 Third Quarter Results

Canada NewsWire November 8, 2018

Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

Canada NewsWire September 19, 2018

Nuvo Pharmaceuticals™ Announces Extension of Exclusivity Period with Aralez and Deerfield

Canada NewsWire August 20, 2018

Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

Canada NewsWire August 10, 2018

Nuvo Pharmaceuticals™ Announces 2018 Second Quarter Results

Canada NewsWire August 2, 2018

Nuvo Pharmaceuticals™(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV for Belgium, the Netherlands and Luxembourg

PR Newswire July 23, 2018

Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting

Canada NewsWire May 10, 2018

Nuvo Pharmaceuticals™ Announces 2018 First Quarter Results

Canada NewsWire May 10, 2018

Nuvo Pharmaceuticals Inc. Presentation Now Available for On-Demand Viewing

PR Newswire April 16, 2018

Nuvo Pharmaceuticals Inc. to Webcast, Live, at VirtualInvestorConferences.com April 11, 2018

PR Newswire April 9, 2018

OTC Markets Group Announces Agenda for OTCQX International Virtual Investor Conference on April 11-12

PR Newswire April 6, 2018

Nuvo Pharmaceuticals™ Announces 2017 Fourth Quarter and Year-End Results

Canada NewsWire March 23, 2018

Nuvo Pharmaceuticals (Ireland) Limited Acquires U.S. Product Rights to Resultz® from Piedmont Pharmaceuticals LLC

Canada NewsWire January 15, 2018

Nuvo Pharmaceuticals Inc.™ Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC

Canada NewsWire January 2, 2018

Nuvo Pharmaceuticals™ Enters into Pennsaid® 2% License Agreement with Gebro Pharma AG for Switzerland and Liechtenstein

PR Newswire December 14, 2017

Nuvo Pharmaceuticals™ Announces Normal Course Issuer Bid

Canada NewsWire November 30, 2017

Nuvo Pharmaceuticals™ Commences Trading on the OTCQX® Market in the U.S.

Canada NewsWire November 28, 2017